About Health Catalyst Capital
Health Catalyst Capital is a venture capital firm founded in 2015. It is primarily based out of New York City, United States. As of Sep 2023, Health Catalyst Capital has invested in 33 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Series B round of Cylinder Health Overall, Health Catalyst Capital portfolio has seen 12 acquisitions including key companies like Cylinder Health, Holmusk and CiOX Health. A lot of funds co-invest with Health Catalyst Capital, with names like Intermountain Ventures sharing a substantial percentage of its portfolio. Health Catalyst Capital has team of 14 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series B & 3 more
Portfolio Acquisitions
Health Catalyst Capital's List of Top Investments
Health Catalyst Capital has a portfolio of 33 companies. Their most notable investments are in Holmusk and PierianDx.Their portfolio spans across United States, India, Netherlands and 1 more locations. They have invested in Enterprise Applications, HealthTech, Life Sciences and 10 other sectors, across stages such as Seed, Series B and 3 more. Here is the list of top investments by Health Catalyst Capital:1. Datavant
Provider of a platform for healthcare professionals to access patient data securely. The solution provides access to patient information, the medical professionals can compare their data to only exchange the records needed.
Key facts about Datavant
- Founded Year: 2017
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $83M
- Employee Count: 7,386 as on Sep 30, 2026
- Investors: Sixth Street, Neuberger Berman and 16 Others
- Latest Funding Round: PE, Sep 17, 2026, $*****
- Highlight: Editors' Pick
2. Medal
Developer of a platform for recording, editing, and sharing game clips. The platform allows users to capture gameplay with a button press and share instantly. It supports automatic clipping for various games and allows importing clips from console systems. The platform offers editing tools, multi-track audio balancing, and customizable clip lengths.
Key facts about Medal
- Founded Year: 2015
- Location: Naarden (Netherlands)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $89.3M
- Employee Count: 111 as on Sep 30, 2026
- Investors: PEAK6, Ridge Ventures and 19 Others
- Latest Funding Round: Series C, Jul 11, 2024, $*****
- Highlight: Editors' Pick
Digital health platform offering solutions for individuals with digestive health issues. It provides care for various digestive health issues, offering individualized care plans designed to address specific symptoms and needs. It offers customized care plans for digestive health needs, virtual access to a dedicated team of doctors, Registered Dietitians, Health Coaches, and more.
Key facts about Cylinder Health
- Founded Year: 2016
- Location: Chicago (United States)
- Stage: Acquired
- Total Funding till date: $77.9M
- Employee Count: 125 as on Sep 30, 2026
- Investors: Mercato Partners, 7wire Ventures and 19 Others
- Latest Funding Round: Series B, Sep 20, 2023, $*****
- Highlight: Acquired
4. HealthMine
Provider of technology and services for healthcare member engagement and quality. The company offers a platform to consolidate member engagement, risk, and quality initiatives. It facilitates personalized, omnichannel outreach and supports digital health risk assessments. The company also provides professional and expert advisory services.
Key facts about HealthMine
- Founded Year: 2008
- Location: San Francisco (United States)
- Stage: Series C
- Total Funding till date: $75M
- Employee Count: 95 as on Sep 30, 2026
- Investors: Saints Capital, Redmile Group and 4 Others
- Latest Funding Round: Series C, Jan 07, 2013, $*****
- Highlight: Editors' Pick
5. Glooko
Glooko is a diabetes management solution for patients, health systems, and payer groups. Glooko’s products enable clinicians to remotely access their patients’ blood glucose readings and other related data, and optimize their insulin therapy. The company’s System allows people with diabetes to download their glucose readings to their mobile devices. According to the company, their population management web app offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. Partners include Abbott, Roche, LifeScan, Medtronic, Omnipod, Bayer, Nipro, and Arkray among others. Glooko and Diasend got merged in September 2016 and the combined companies operate under the Glooko moniker.
Key facts about Glooko
- Founded Year: 2010
- Location: Palo Alto (United States)
- Stage: Series F
- Total Funding till date: $201M
- Employee Count: 239 as on Sep 30, 2026
- Investors: Georgian, Canaan and 22 Others
- Latest Funding Round: Series F, Oct 10, 2024, $*****
- Highlight: Editors' Pick
Health Catalyst Capital's Year-on-Year Investment Trends
Health Catalyst Capital has invested in 33 companies over the last 11 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in Cylinder Health and most recent follow-on round was in Clearsense.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 1 | 3 | 4 |
2022 | 0 | 0 | 0 |
2021 | 5 | 4 | 9 |
2020 | 1 | 1 | 2 |
2019 | 3 | 2 | 5 |
2018 | 2 | 0 | 2 |
2017 | 1 | 0 | 1 |
Health Catalyst Capital's Investments by Stage
Health Catalyst Capital has made 5 investments in Seed stage with an average round size of $1.75M, 4 investments in Series B stage with an average round size of $25.3M, 3 investments in Series A stage with an average round size of $21.5M, 2 investments in Series C stage with an average round size of $50M and 1 investment in Series D stage with an average round size of $30M.Stage of entry | No. of Investments |
|---|---|
Seed | 5 |
Series B | 4 |
Series A | 3 |
Series C | 2 |
Series D | 1 |
Note: We have considered here, only first round of investments
Health Catalyst Capital's Investments by Sector
Health Catalyst Capital has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Vertical SaaS, High Tech and Life Sciences. Notably, it has invested in 31 Tech companies, 27 Enterprise (B2B) companies, 26 Software companies and at least 20 companies focusing on Saas.Sector | No. of Investments |
|---|---|
HealthTech | 12 |
Enterprise Applications | 10 |
Vertical SaaS | 6 |
High Tech | 2 |
Life Sciences | 2 |
Others | 5 |
Note: We have considered here, only first round of investments
Health Catalyst Capital's Investments by Geography
Health Catalyst Capital has made most investments in United States (13), followed by Netherlands where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 13 |
Netherlands | 1 |
Singapore | 1 |
Note: We have considered here, only first round of investments
Health Catalyst Capital's recent investments
Health Catalyst Capital has not made any investment in 2026 so far.Here are the most recent investments by Health Catalyst Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 20, 2023 | United States | Series B | 1177 | [+4] | |
Jan 31, 2023 | United States | Series D | 3362 | [+1] | |
Jan 10, 2023 | United States | Series B | 1366 | ||
Jan 09, 2023 | Singapore | Series B | 5963 | [+3] | |
Dec 06, 2021 | Singapore | Series A | 7424 | [+3] |
Acquired companies in Health Catalyst Capital's Portfolio
12 companies from Health Catalyst Capital's portfolio have been acquired. The most recent acquisition was Cylinder Health in Aug 2026 by Hinge Health for $*****.Here are Health Catalyst Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 05, 2026 | Sep 20, 2023 | Series B | 9296 | |
May 02, 2025 | Feb 21, 2019 | Series A | 5999 | |
Jan 13, 2023 | 2015 | Seed | 1853 | |
Jul 12, 2022 | May 18, 2020 | Series A | 1788 | |
Jan 06, 2022 | - | - | 6232 |
Team profile of Health Catalyst Capital
Health Catalyst Capital has a team of 14 members including 1 Partner and 1 Principal located in United States. Health Catalyst Capital's team does not sit on the board of any company as of now.Co-investors of Health Catalyst Capital
Over the past 11 years, 114 investors have co-invested in Health Catalyst Capital's portfolio companies. This includes funds and angels.
- Invested before Health Catalyst Capital: Uncork Capital, Zhen Fund and 51 others have invested in rounds before Health Catalyst Capital. There are 2 companies where Uncork Capital has invested before Health Catalyst Capital and 1 company where Zhen Fund has invested before Health Catalyst Capital.
- Top Co-investors of Health Catalyst Capital: 27 investors entered a company along with Health Catalyst Capital. These include investors like Intermountain Ventures (1 company).
- Invested after Health Catalyst Capital: A total of 34 investors have invested in Health Catalyst Capital's portfolio after their investments. Top Investors include Backed (1 company), Initial Capital (1 company) and Ridge Ventures (1 company).
Recent News related to Health Catalyst Capital
•
Catalyst Capital Markets Launches With a Focus on Micro/Small Cap and Private Issuer Capital AdvisoryNewswire•Feb 19, 2025•Health Catalyst Capital
•
•
Glooko raises €91 million and appoints Mike Alvarez as new CEOConsalud•Oct 11, 2024•Glooko, Georgian, Health Catalyst Capital, Canaan
•
Why Georgian Invested in Glooko (Again)Georgian•Oct 10, 2024•Glooko, Georgian, Health Catalyst Capital, Canaan
•
Glooko Secures $100M, Appoints Mike Alvarez as New CEOHIT Consultant•Oct 10, 2024•Glooko, Georgian, Health Catalyst, Canaan and 1 other
•
Health Catalyst Capital Management debuts Quarvis Health via portfolio company mergerPE Hub•Jul 05, 2024•Health Catalyst Capital
•
Mercato Leads $31 Million Series B Investment in Vivante Health ...TechBuzz•Sep 21, 2023•Human Capital, Intermountain Healthcare, Mercato Partners, Health Catalyst Capital and 9 others
•
Clearsense Raises $50M in Series D FundingFinSMEs•Feb 10, 2023•Clearsense, Health Quest Capital, Health Catalyst Capital, UPMC Enterprises and 1 other
•
Clearsense Announces Success of $50M Capital RaiseNewswire•Jan 31, 2023•Clearsense, Health Quest Capital, Health Catalyst Capital, UPMC Enterprises
•
Northwell Holdings, Veradigm part of $45M funding round for HolmuskBecker's Hospital Review•Jan 10, 2023•Holmusk, Northwell, Veradigm, Catalyst Capital and 4 others
